[go: up one dir, main page]

TW200631584A - A medicament related to mirtazapine for the treatment of hot flush - Google Patents

A medicament related to mirtazapine for the treatment of hot flush

Info

Publication number
TW200631584A
TW200631584A TW094139442A TW94139442A TW200631584A TW 200631584 A TW200631584 A TW 200631584A TW 094139442 A TW094139442 A TW 094139442A TW 94139442 A TW94139442 A TW 94139442A TW 200631584 A TW200631584 A TW 200631584A
Authority
TW
Taiwan
Prior art keywords
mirtazapine
treatment
hot flush
medicament related
medicament
Prior art date
Application number
TW094139442A
Other languages
English (en)
Inventor
Bernardus Wijnand Mathys Marie Peeters
Anton Egbert Peter Adang
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200631584(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of TW200631584A publication Critical patent/TW200631584A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW094139442A 2004-11-15 2005-11-10 A medicament related to mirtazapine for the treatment of hot flush TW200631584A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15

Publications (1)

Publication Number Publication Date
TW200631584A true TW200631584A (en) 2006-09-16

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094139442A TW200631584A (en) 2004-11-15 2005-11-10 A medicament related to mirtazapine for the treatment of hot flush

Country Status (30)

Country Link
US (4) US20070265245A1 (zh)
EP (1) EP1814555B1 (zh)
JP (1) JP2008519810A (zh)
KR (1) KR20070085470A (zh)
CN (2) CN101056641A (zh)
AR (1) AR053780A1 (zh)
AT (1) ATE439843T1 (zh)
AU (1) AU2005303778B2 (zh)
BR (1) BRPI0517818A2 (zh)
CA (1) CA2587283C (zh)
CY (1) CY1110538T1 (zh)
DE (1) DE602005016141D1 (zh)
DK (1) DK1814555T3 (zh)
ES (1) ES2329815T3 (zh)
HR (1) HRP20090513T1 (zh)
IL (1) IL182767A (zh)
MX (1) MX2007005827A (zh)
MY (1) MY144089A (zh)
NO (1) NO20072285L (zh)
NZ (1) NZ554858A (zh)
PE (1) PE20061051A1 (zh)
PL (1) PL1814555T3 (zh)
PT (1) PT1814555E (zh)
RS (1) RS51138B (zh)
RU (1) RU2396957C2 (zh)
SI (1) SI1814555T1 (zh)
TW (1) TW200631584A (zh)
UA (1) UA88655C2 (zh)
WO (1) WO2006051111A1 (zh)
ZA (1) ZA200703884B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
CA2644985A1 (en) * 2006-03-06 2007-09-13 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
EP2091541A1 (en) * 2006-11-22 2009-08-26 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
PT3261645T (pt) 2015-02-27 2021-06-17 Dechra Ltd Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos
CA3064846A1 (en) * 2017-05-25 2018-11-29 Glytech, Llc Combined therapy for nmdar antagonist-responsive neuropsychiatric disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
DK1067934T3 (da) * 1998-04-02 2004-03-29 Akzo Nobel Nv Flydende oral opløsning omfattende det anti-depressive middel mirtazapin
RU2195951C1 (ru) * 2001-08-20 2003-01-10 Общество с ограниченной ответственностью "Лаборатория "Ирис" Средство для лечения климактерических расстройств

Also Published As

Publication number Publication date
CA2587283A1 (en) 2006-05-18
AU2005303778A1 (en) 2006-05-18
MX2007005827A (es) 2007-07-20
CA2587283C (en) 2013-01-15
HRP20090513T1 (hr) 2009-10-31
DK1814555T3 (da) 2009-12-07
CY1110538T1 (el) 2015-04-29
RU2007122391A (ru) 2008-12-20
DE602005016141D1 (de) 2009-10-01
RU2396957C2 (ru) 2010-08-20
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
EP1814555A1 (en) 2007-08-08
MY144089A (en) 2011-08-15
CN102772414A (zh) 2012-11-14
US20070265245A1 (en) 2007-11-15
KR20070085470A (ko) 2007-08-27
US20100267694A1 (en) 2010-10-21
US20120302552A1 (en) 2012-11-29
HK1104235A1 (zh) 2008-01-11
RS51138B (sr) 2010-10-31
US20130225559A1 (en) 2013-08-29
NZ554858A (en) 2009-10-30
UA88655C2 (ru) 2009-11-10
AU2005303778B2 (en) 2011-02-17
ES2329815T3 (es) 2009-12-01
BRPI0517818A2 (pt) 2010-03-16
EP1814555B1 (en) 2009-08-19
IL182767A (en) 2011-07-31
AR053780A1 (es) 2007-05-23
PL1814555T3 (pl) 2010-01-29
PT1814555E (pt) 2009-09-30
IL182767A0 (en) 2007-09-20
NO20072285L (no) 2007-06-13
ATE439843T1 (de) 2009-09-15
CN101056641A (zh) 2007-10-17
SI1814555T1 (sl) 2009-12-31
JP2008519810A (ja) 2008-06-12
PE20061051A1 (es) 2006-10-26

Similar Documents

Publication Publication Date Title
IL181305A0 (en) Combinations for the treatment of diseases involving cell proliferation
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
PT2073811E (pt) Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas
IL182533A0 (en) Prostate treatment stent
IL177490A0 (en) Methods for the treatment of tinnitus induced by cochlear excitotoxicity
WO2010077589A3 (en) Stat3 inhibitors and therapeutic methods using the same
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
NO20072285L (no) S-mirtazapin for behandling av hetetokter
SG152237A1 (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
GB0416508D0 (en) Therapeutic agents
SG10201408374WA (en) Therapeutic Combinations Of Theobromine And An Antihistamine
IL178827A0 (en) Use of reboxetine for the treatment of pain
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
PH12012500955A1 (en) Drug combination with theobromine and its use in therapy
ATE489947T1 (de) Axomadol zur schmerzbehandlung bei arthrose
CA118534S (en) Bathtub
UA6623U (en) Method for increasing therapeutic efficacy of clays
HU0600490D0 (en) Medical use of chelidonium mejs, gacid, cinadane
AU315487S (en) Tallboy
AU315484S (en) Bed
AU320471S (en) Ball-of-foot cushions
PL369395A1 (pl) Sposób wytwarzania trumien papierowo-tekturowych
UA11522U (uk) Спосіб профілактики гнійно-запальних ускладнень пологових травм промежини
UA27187U (en) Method for complex treatment of arterial hypertension in patients of young age
GB0417867D0 (en) Treatment of pipes